LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

Search

Merit Medical Systems Inc

Закрыт

СекторЗдравоохранение

81.23 -1.1

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

79.48

Макс.

82.18

Ключевые показатели

By Trading Economics

Доход

-4.8M

28M

Продажи

1.7M

384M

P/E

Средняя по отрасли

41.451

121.746

Рентабельность продаж

7.225

Сотрудники

7,400

EBITDA

-4.4M

80M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+30.31% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

24 февр. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-108M

4.8B

Предыдущая цена открытия

82.33

Предыдущая цена закрытия

81.23

Новостные настроения

By Acuity

50%

50%

149 / 352 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Strong Bullish Evidence

Merit Medical Systems Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

11 февр. 2026 г., 23:47 UTC

Популярные акции

Stocks to Watch: AppLovin, Cisco, Cognex, Pilgrim's Pride

11 февр. 2026 г., 22:59 UTC

Отчет
Приобретения, слияния, поглощения

Grab Holdings to Buy U.S.-Based Stash Financial

11 февр. 2026 г., 23:54 UTC

Отчет

McDonald's Says Its Value Campaign Is Paying Off -- 2nd Update

11 февр. 2026 г., 23:50 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

11 февр. 2026 г., 23:50 UTC

Обсуждения рынка

Nikkei May Rise on Hopes for Takaichi's Economic Steps -- Market Talk

11 февр. 2026 г., 23:49 UTC

Отчет

Singtel: Key Focus Areas Are Strengthening Core Businesses, Scaling Growth Engines, Building Momentum Across Regional Associates >Z74.SG

11 февр. 2026 г., 23:45 UTC

Отчет

Singtel: Net Exceptional Gain of S$1.15B in 3Q Primarily From Sale of Partial Stake in Bharti Airtel>Z74.SG

11 февр. 2026 г., 23:42 UTC

Отчет

Singtel 3Q Underlying Net Profit S$744M Vs. S$680M >Z74.SG

11 февр. 2026 г., 23:41 UTC

Отчет

Singtel 3Q Net S$1.89B Vs. Net S$1.32B >Z74.SG

11 февр. 2026 г., 23:40 UTC

Отчет

Singtel 3Q Operating Revenue S$3.66B Vs. S$3.63B >Z74.SG

11 февр. 2026 г., 23:35 UTC

Обсуждения рынка

Gold Falls on Prospects of Long Fed Pause -- Market Talk

11 февр. 2026 г., 23:18 UTC

Обсуждения рынка

AppLovin CEO Looks to Soothe Concerns Over AI, Competition -- Market Talk

11 февр. 2026 г., 23:14 UTC

Обсуждения рынка

RBA Governor Faces Barrage of Questions About Govt Spending -- Market Talk

11 февр. 2026 г., 22:59 UTC

Отчет

Kakao 2025 Net KRW525.72B Vs. Loss KRW161.87B >035720.SE

11 февр. 2026 г., 22:59 UTC

Отчет

Kakao 2025 Oper Pft KRW732.04B Vs. Pft KRW460.21B >035720.SE

11 февр. 2026 г., 22:59 UTC

Отчет

Kakao 2025 Rev KRW8.099T Vs. KRW7.872T >035720.SE

11 февр. 2026 г., 22:58 UTC

Отчет

Kakao 4Q Net Loss Missed FactSet-Compiled Consensus

11 февр. 2026 г., 22:57 UTC

Отчет

Kakao 4Q Loss KRW39.30B Vs. Loss KRW395.21B >035720.SE

11 февр. 2026 г., 22:54 UTC

Отчет

Kakao 4Q Oper Pft KRW203.45B Vs. Pft KRW75.43B >035720.SE

11 февр. 2026 г., 22:53 UTC

Отчет

Kakao 4Q Rev KRW2.133T Vs. KRW1.957T >035720.SE

11 февр. 2026 г., 22:47 UTC

Отчет

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11 февр. 2026 г., 22:47 UTC

Отчет

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11 февр. 2026 г., 22:23 UTC

Отчет

Grab Holdings Expects to Close Stash Acquisition in 3Q of 2026 >GRAB

11 февр. 2026 г., 22:22 UTC

Отчет

Grab Holdings to Acquire U.S. Digital Financial Services Company Stash Financial >GRAB

11 февр. 2026 г., 22:22 UTC

Отчет

Grab Holdings Sees FY26 Adj Ebitda $700M to $720M >GRAB

11 февр. 2026 г., 22:19 UTC

Отчет

Grab Holdings Sees FY26 Rev $4.04B to $4.10B >GRAB

11 февр. 2026 г., 22:18 UTC

Отчет

Grab Holdings 4Q Adj Ebitda $148.0M Vs. $97.0M >GRAB

11 февр. 2026 г., 22:18 UTC

Отчет

Grab Holdings 4Q Net $153.0M Vs. Net $11.0M >GRAB

11 февр. 2026 г., 22:18 UTC

Отчет

Grab Holdings 4Q Oper Pft $52.0M Vs. $2.0M >GRAB

11 февр. 2026 г., 22:16 UTC

Отчет

Grab Holdings 4Q Rev $906.0M Vs. $764.0M >GRAB

Сравнение c конкурентами

Изменение цены

Merit Medical Systems Inc Прогноз

Целевая цена

By TipRanks

30.31% рост

Прогноз на 12 месяцев

Средняя 105.33 USD  30.31%

Максимум 122 USD

Минимум 90 USD

Основано на мнении 9 аналитиков Wall Street, спрогнозировавших целевые цены для Merit Medical Systems Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

9 ratings

8

Покупка

1

Удержание

0

Продажа

Техническая оценка

By Trading Central

95.585 / 96.35Поддержка и Сопротивление

Краткосрочная

Strong Bullish Evidence

Среднесрочная

Bearish Evidence

Долгосрочная

Bearish Evidence

Настроения

By Acuity

149 / 352Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Merit Medical Systems Inc

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
help-icon Live chat